These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3987083)

  • 1. Impact of methotrexate therapy on the folate status of psoriatic patients.
    Hendel J; Nyfors A
    Clin Exp Dermatol; 1985 Jan; 10(1):30-5. PubMed ID: 3987083
    [No Abstract]   [Full Text] [Related]  

  • 2. Intestinal folate absorption in methotrexate treated psoriatic patients.
    Duhra P; Hodgson C; Martin JA; Stableforth PJ
    Br J Dermatol; 1988 Sep; 119(3):327-32. PubMed ID: 3179205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of methotrexate in erythrocytes in psoriasis.
    Hendel J; Nyfors A
    Eur J Clin Pharmacol; 1984; 27(5):607-10. PubMed ID: 6519167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate hepatotoxicity and concentrations of methotrexate and folate in erythrocytes--relation to liver fibrosis and cirrhosis.
    Zachariae H; Schrøder H; Foged E; Søgaard H
    Acta Derm Venereol; 1987; 67(4):336-40. PubMed ID: 2445154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum interleukin-6 levels in response to methotrexate treatment in psoriatic patients.
    Elango T; Dayalan H; Subramanian S; Gnanaraj P; Malligarjunan H
    Clin Chim Acta; 2012 Oct; 413(19-20):1652-6. PubMed ID: 22609260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with drug survival of methotrexate and acitretin in patients with psoriasis.
    Shalom G; Zisman D; Harman-Boehm I; Biterman H; Greenberg-Dotan S; Polishchuk I; Moser H; Freud T; Feldhamer I; Cohen AD
    Acta Derm Venereol; 2015 Nov; 95(8):973-7. PubMed ID: 25950855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis.
    Chládek J; Simková M; Vanecková J; Hroch M; Chládkova J; Martínková J; Vávrová J; Beránek M
    Eur J Clin Pharmacol; 2008 Apr; 64(4):347-55. PubMed ID: 18163165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of folic acid supplementation in psoriasis patients receiving methotrexate: a survey in the United Kingdom.
    Kirby B; Lyon CC; Griffiths CE; Chalmers RJ
    Clin Exp Dermatol; 2000 Jun; 25(4):265-8. PubMed ID: 10971481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate supplementation during methotrexate therapy for patients with psoriasis.
    Strober BE; Menon K
    J Am Acad Dermatol; 2005 Oct; 53(4):652-9. PubMed ID: 16198787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in liver histology during methotrexate therapy of psoriasis correlated to the concentration of methotrexate and folate in erythrocytes.
    Hendel J; Poulsen H; Nyfors B; Nyfors A
    Acta Pharmacol Toxicol (Copenh); 1985 Apr; 56(4):321-6. PubMed ID: 4024960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of methotrexate in psoriasis therapy.
    Hendel J
    Dan Med Bull; 1985 Dec; 32(6):329-37. PubMed ID: 3908004
    [No Abstract]   [Full Text] [Related]  

  • 12. Methotrexate in erythrocytes of patients with psoriasis.
    Schrøder H; Foged EK
    Eur J Clin Pharmacol; 1986; 30(4):453-6. PubMed ID: 3743621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal calmodulin levels in psoriasis before & after therapy.
    Kaur I; Kaur S; Vaishnavi C; Ganguly NK; Garg J; Kohli M
    Indian J Med Res; 1991 Apr; 94():130-3. PubMed ID: 1879887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement.
    Hornung N; Ellingsen T; Stengaard-Pedersen K; Poulsen JH
    J Rheumatol; 2004 Dec; 31(12):2374-81. PubMed ID: 15570637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid - Who does what with methotrexate?
    Randhawa A; Blair R; Wylie G
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):e469-e470. PubMed ID: 28423206
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of psoriasis with minute divided oral doses of methotrexate.
    Spiro JM; Demis DJ
    Arch Dermatol; 1969 Apr; 99(4):459-64. PubMed ID: 4238827
    [No Abstract]   [Full Text] [Related]  

  • 17. Is methotrexate safe in the treatment of psoriatic patients?
    Al-Waiz MM; Jafar SJ
    Saudi Med J; 2004 Apr; 25(4):536-7. PubMed ID: 15083237
    [No Abstract]   [Full Text] [Related]  

  • 18. Interruption of long-term methotrexate treatment in psoriasis. Evaluation of clinical course and laboratory parameters after discontinuation and reintroduction of weekly oral methotrexate.
    van Dooren-Greebe RJ; Kuijpers AL; Termorshuizen F; van de Kerkhof PC
    Acta Derm Venereol; 1995 Sep; 75(5):393-6. PubMed ID: 8615062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent, short term use of methotrexate for exacerbations of psoriasis.
    Clark AR; Feldman SR
    Int J Dermatol; 1997 Dec; 36(12):954-5. PubMed ID: 9466209
    [No Abstract]   [Full Text] [Related]  

  • 20. Topical treatment of psoriatic skin with methotrexate cream: a clinical, pharmacokinetic, and histological study.
    Bjerring P; Beck HI; Zachariae H; Søgaard H
    Acta Derm Venereol; 1986; 66(6):515-9. PubMed ID: 2433872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.